Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
7.54
-0.30 (-3.83%)
At close: Sep 9, 2026, 4:00 PM EDT
7.80
+0.26 (3.39%)
After-hours: Sep 9, 2026, 7:30 PM EDT
Achieve Life Sciences Market Cap
Achieve Life Sciences has a market cap or net worth of $775.88 million as of September 9, 2026. Its market cap has increased by 418.29% in one year.
Market Cap
775.88M
Enterprise Value
603.53M
1-Year Change
418.29%
Ranking
Category
Stock Price
$7.54
ChartMarket Cap Chart
Since December 1, 1998, Achieve Life Sciences's market cap has increased from $67.40M to $775.88M, an increase of 1,051.16%. That is a compound annual growth rate of 9.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 775.88M | 193.23% |
| Dec 31, 2025 | 264.60M | 118.50% |
| Dec 31, 2024 | 121.10M | 38.88% |
| Dec 29, 2023 | 87.20M | 266.39% |
| Dec 30, 2022 | 23.80M | -67.62% |
| Dec 31, 2021 | 73.50M | 150.85% |
| Dec 31, 2020 | 29.30M | 565.91% |
| Dec 31, 2019 | 4.40M | -45.68% |
| Dec 31, 2018 | 8.10M | -49.38% |
| Dec 29, 2017 | 16.00M | 6.67% |
| Dec 30, 2016 | 15.00M | -58.45% |
| Dec 31, 2015 | 36.10M | -25.87% |
| Dec 31, 2014 | 48.70M | -60.31% |
| Dec 31, 2013 | 122.70M | -36.19% |
| Dec 31, 2012 | 192.30M | 68.09% |
| Dec 30, 2011 | 114.40M | -29.47% |
| Dec 31, 2010 | 162.20M | 20.59% |
| Dec 31, 2009 | 134.50M | 715.15% |
| Dec 31, 2008 | 16.50M | 1.23% |
| Dec 31, 2007 | 16.30M | -92.75% |
| Dec 29, 2006 | 224.80M | 47.89% |
| Dec 30, 2005 | 152.00M | 101.86% |
| Dec 31, 2004 | 75.30M | -17.34% |
| Dec 31, 2003 | 91.10M | 214.14% |
| Dec 31, 2002 | 29.00M | -68.75% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 941.93M |
| Olema Pharmaceuticals | 940.60M |
| Annexon | 923.25M |
| Rigel Pharmaceuticals | 909.15M |
| Aclaris Therapeutics | 908.22M |
| Crescent Biopharma | 893.69M |
| Cybin | 892.80M |
| Climb Bio | 891.41M |